Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 4/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 4/20 | 0.36 |
| ▸ | MMP13 | P45452 | 4/20 | 0.36 |
| ▸ | MMP9 | P14780 | 3/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP7 | P09237 | 1/20 | 0.36 |
| ▸ | PRKAA2 | P54646 | 4/20 | 0.35 |
| ▸ | WNT3 | P56703 | 3/20 | 0.34 |
| ▸ | SFRP1 | Q8N474 | 3/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21036254 | 1.00 | CCR4 (0.40) | CCR4ROCK2PARP1PARP2MMP1 | |
| SCHEMBL21034935 | 0.91 | CCR4 (0.42) | CCR4ROCK2MMP1MMP13MMP9 | |
| SCHEMBL21035343 | 0.88 | CCR4 (0.42) | CCR4ROCK2PARP1PARP2MMP1 | |
| SCHEMBL21035330 | 0.88 | CCR4 (0.42) | CCR4ROCK2PARP1PARP2MMP1 | |
| SCHEMBL21035072 | 0.88 | CCR4 (0.42) | CCR4ROCK2PARP1PARP2MMP1 | |
| SCHEMBL21002090 | 0.88 | MMP1 (0.37) | CCR4ROCK2MMP1MMP13MMP9 | |
| SCHEMBL21002092 | 0.88 | MMP1 (0.37) | CCR4ROCK2MMP1MMP13MMP9 | |
| SCHEMBL21035486 | 0.87 | MMP13 (0.39) | CCR4MMP1MMP13MMP9MMP3 | |
| SCHEMBL21036241 | 0.87 | MMP13 (0.39) | CCR4MMP1MMP13MMP9MMP3 | |
| SCHEMBL21036224 | 0.86 | GHSR (0.41) | CCR4MMP1MMP13MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019104011-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-05-31 | — | — | WO | disclosed |